MG
CORZ

Michael Gelband’s Core Scientific, Inc. Common Stock CORZ Stock Holding History

Michael Gelband’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11,889
Closed -$18K – 2463
2022
Q2 		$18K Sell
11,889
-84,512
-88% -$388K ﹤0.01% 1855
2022
Q1 		$793K Buy
+96,401
New +$852K 0.01% 1286

Other funds holding CORZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
SFS
Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return
JWM
JGP Wealth Management Bend, Oregon $1.11B AUM 35.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Michael Gelband's CORZ Position: Q3 2022 in Review

Michael Gelband sold out of Core Scientific, Inc. Common Stock (CORZ) in Q3 2022, closing a stake of 11,889 shares — an estimated $18K sold.

Michael Gelband first reported a position in CORZ in Q1 2022 and held it in 2 quarters. The position peaked at $793K in Q1 2022. 137 funds tracked by Wall St. Rank hold CORZ as of Q3 2022.

  • Michael Gelband reported no remaining Core Scientific, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Michael Gelband sold 11,889 Core Scientific, Inc. Common Stock shares in Q3 2022, an estimated $18K.
  • Michael Gelband first reported a position in Core Scientific, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • Michael Gelband's Core Scientific, Inc. Common Stock position peaked at $793K in Q1 2022.
  • 137 funds tracked by Wall St. Rank held Core Scientific, Inc. Common Stock as of Q3 2022.

Based on ExodusPoint Capital Management's 13F filing for Q3 2022, filed 10 Nov 2022.